AKERO THERAPEUTICS INC. - COMMON STOCK
20.80
09-5月-24 15:59:59
15 分の遅延
株式
-0.22
-1.05%
本日の幅
20.54 - 21.21
ISIN
N/A
ソース
NASDAQ
-
Akero Therapeutics to Present at the BofA Securities 2024 Health Care Conference
08 5 2024 07:00:01 提供 Nasdaq GlobeNewswire
-
Akero Therapeutics Appoints Scott Gangloff as Chief Technology Officer
30 4 2024 08:00:01 提供 Nasdaq GlobeNewswire
-
08 3 2024 16:02:00 提供 Nasdaq GlobeNewswire
-
07 3 2024 16:01:00 提供 Nasdaq GlobeNewswire
-
Akero Therapeutics Announces Pricing of Public Offering of Common Stock
05 3 2024 21:13:56 提供 Nasdaq GlobeNewswire
-
Akero Therapeutics Announces Proposed Public Offering of Common Stock
04 3 2024 16:21:12 提供 Nasdaq GlobeNewswire
-
04 3 2024 06:00:00 提供 Nasdaq GlobeNewswire
-
29 2 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
29 2 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
Akero Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
03 1 2024 08:15:00 提供 Nasdaq GlobeNewswire
-
Akero Therapeutics Announces First Patients Dosed in Efruxifermin Phase 3 SYNCHRONY Program
18 12 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
Akero Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
13 11 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
10 11 2023 08:57:33 提供 Nasdaq GlobeNewswire
-
Akero Therapeutics to Present at Upcoming Healthcare Conferences in November
08 11 2023 07:00:01 提供 Nasdaq GlobeNewswire
-
Akero Therapeutics to Present at the H.C. Wainwright 7th Annual NASH Virtual Investor Conference
17 10 2023 16:05:00 提供 Nasdaq GlobeNewswire
-
10 10 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
09 10 2023 16:05:00 提供 Nasdaq GlobeNewswire
-
04 10 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
Akero Therapeutics to Present at Upcoming Healthcare Conferences in September
31 8 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
Akero Therapeutics to Report Results of Phase 2b SYMMETRY Study in October 2023
28 8 2023 07:00:00 提供 Nasdaq GlobeNewswire
- <<
- <
- 1
- >